Literature DB >> 19994429

Adverse Reactions to Corticosteroid Therapy in the Eye.

S J Crews.   

Abstract

Year:  1965        PMID: 19994429      PMCID: PMC1898645     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

1.  CORTICOSTEROIDS IN CORNEAL WOUND HEALING.

Authors:  J V AQUAVELLA; A R GASSET; C H DOHLMAN
Journal:  Am J Ophthalmol       Date:  1964-10       Impact factor: 5.258

2.  [EVOLUTION OF CRYSTALLINE OPACITY FOLLOWING LOCAL CORTISONE THERAPY].

Authors:  E B STREIFF
Journal:  Ophthalmologica       Date:  1964       Impact factor: 3.250

3.  OBSERVATION OF RETINOPATHY IN METAHYPOPHYSEAL DIABETIC CHINESE HAMSTERS.

Authors:  H R HAUSLER; B STACHOWSKA; T M SIBAY
Journal:  Invest Ophthalmol       Date:  1963-08

4.  Posterior subcapsular lens opacities in patients on longterm corticosteroid therapy.

Authors:  S J CREWS
Journal:  Br Med J       Date:  1963-06-22

5.  Vitamin-A intoxication.

Authors:  C A TURTZ; A I TURTZ
Journal:  Am J Ophthalmol       Date:  1960-07       Impact factor: 5.258

6.  Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis.

Authors:  R L BLACK; R B OGLESBY; L VON SALLMANN; J J BUNIM
Journal:  JAMA       Date:  1960-09-10       Impact factor: 56.272

7.  Diabetic retinopathy.

Authors:  B BECKER
Journal:  Ann Intern Med       Date:  1952-08       Impact factor: 25.391

  7 in total
  3 in total

1.  Macular lesions during systemic therapy with depot tetracosactrin.

Authors:  J Williamson; G Nuki
Journal:  Br J Ophthalmol       Date:  1970-06       Impact factor: 4.638

2.  Examination for posterior subcapsular cataracts in patients treated with topical steroids.

Authors:  J Williamson; M K Jasani
Journal:  Br J Ophthalmol       Date:  1967-08       Impact factor: 4.638

3.  Cortisone cataract in children with nephrotic syndrome.

Authors:  H J Bachmann; P Schildberg; H Olbing; D Krämer; T Waubke
Journal:  Eur J Pediatr       Date:  1977-03-18       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.